BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6359726)

  • 1. [Betamed in the treatment of psychogenic disorders with a somatic component].
    Jellinger K
    Wien Med Wochenschr; 1983 Sep; 133(18):463-7. PubMed ID: 6359726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bromazepam in the treatment of somatized psychogenic disorders (author's transl)].
    Podiwinsky F; Jellinger K
    Wien Klin Wochenschr; 1979 Mar; 91(7):240-4. PubMed ID: 34934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flupenthixol versus diazepam in the treatment of psychosomatic disorders: a double-blind, multi-centre trial in general practice.
    Jokinen K; Koskinen T; Selonen R
    Pharmatherapeutica; 1984; 3(9):573-81. PubMed ID: 6374678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A group of patients with neuroses with principally somatic manifestations treated with the combination of sulpiride and diazepam].
    Colucci D'Amato C; Mundo P; Pellegrino L; Zivelli G
    Acta Neurol (Napoli); 1976; 31(4):501-8. PubMed ID: 1026065
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the use of Librium and Valium in general medicine, in adults].
    Chassagnon C
    J Med Lyon; 1967 Jun; 48(123):1059-80. PubMed ID: 5618071
    [No Abstract]   [Full Text] [Related]  

  • 7. [A controlled double-blind crossover study of the efficacy of mepiprazol (EMD 16.923) and of diazepam in the treatment of neurotic disorders].
    De Buck R; Van Durme R; Pelc I
    Acta Psychiatr Belg; 1975 May; 75(3):320-33. PubMed ID: 769484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-centre comparison of prazepam and diazepam in the treatment of anxiety.
    Dorman T
    Pharmatherapeutica; 1983; 3(6):433-40. PubMed ID: 6353434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosomatic disorders in general practice: comparisons of treatment with flupenthixol, diazepam and sulpiride.
    Meyers C; Vranckx C; Elgen K
    Pharmatherapeutica; 1985; 4(4):244-50. PubMed ID: 3903789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-week trial with diazepam: some clinical observations.
    Rickels K; Downing RW; Case GW; Csanalosi I; Chung H; Winokur A; Gingrich RL
    J Clin Psychiatry; 1985 Nov; 46(11):470-4. PubMed ID: 3902806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clobazam (Frisium) in everyday practice. An open six-months' study of its efficacy and tolerance (author's transl)].
    Radmayr E; Koeppen D
    MMW Munch Med Wochenschr; 1977 Dec; 119(50):1623-6. PubMed ID: 23493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of a new benzodiazepine preparation, S-804, for the treatment of psychoneurotic and psychosomatic disorders by double-blind cross-over test].
    Tanaka H; Takayama I; Ookubo N; Yoshimuta S; Kono Y
    Saishin Igaku; 1970 May; 25(5):1128-36. PubMed ID: 4912179
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of depressive anxiety states associated with psychosomatic symptoms. A double-blind multicentre clinical study: mianserin versus melitracen-flupentixol.
    Van Moffaert M; Dierick M; De Meulemeester F; Vereecken A
    Acta Psychiatr Belg; 1983; 83(5):525-39. PubMed ID: 6670581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amitriptyline in the treatment of anxiety and insomnia anal as a tranquilizer].
    Díaz Solano C
    Neurol Neurocir Psiquiatr; 1976; 17(3):133-8. PubMed ID: 1004677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [D,L-kavain in comparison with oxazepam in anxiety disorders. A double-blind study of clinical effectiveness].
    Lindenberg D; Pitule-Schödel H
    Fortschr Med; 1990 Jan; 108(2):49-50, 53-4. PubMed ID: 2179082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxazepam-protriptyline: a double-blind phase II evaluation of the efficacy and safety of the combination versus placebo in neurotic, depressed and anxious psychiatric outpatients.
    Gilbert MM; Koepke HH
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):825-38. PubMed ID: 813948
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug interactions in controlled clinical trials.
    Gershon S
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):95-9. PubMed ID: 6130080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative evaluation of the effect of minor tranquilizers, benzodiazepine derivatives, medazepam (S-804) and diazepam on psychosomatic symptoms--estimtion of dosage ratio by the double blind method].
    Fukuda I; Kamide H; Higuchi H; Fujiwara K; Nakamura Y
    Saishin Igaku; 1971 Aug; 26(8):1564-7. PubMed ID: 4936623
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicenter evaluation of maprotiline hydrochloride for treatment of depression.
    Clin Ther; 1984; 6(2):155-62. PubMed ID: 6367987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.